Personalized Medicine in Oncology

Home
About
Contact
Issue Archive
Special Issues
Supplements

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

PMO Print Edition

PMO Weekly e‑Newsletter

I have reviewed and consent to the terms of PMO's Privacy Policy, and PMO has my permission to retain my information in its database, and to forward pertinent communications to me.

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
Videos

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
Videos

Home
About
Contact
Issue Archive
Special Issues
Supplements

Emerging Therapies

TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
Two New Therapies Active in NSCLC with EGFR/HER2 Exon 20 Mutations

Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia

Identifying and Solving Top Challenges to Oncology Biomarker Testing
Overcoming Challenges to Molecular Biomarker Testing
Impact of Reimbursement for Biomarker Testing on Clinical Practice

In the News

May 19, 2016

Two-pronged attack on chemotherapy-resistant leukemia cells

May 18, 2016

An Early Look at Research From the 2016 ASCO Annual Meeting

May 18, 2016

Drug against breast cancer is also highly potent against a frequent form of leukaemia

May 17, 2016

Improving natural killer cancer therapy: Study

Keep up to date with all of our news! Sign me up!

Copyright 2023. Amplity Medical Communications. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse this site, you agree to our use of cookies.